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ERRATUM
In the February 2005 issue of the Journal, in the article
entitled “Dent Disease with Mutations in OCRL1” by Hoo-
pes et al. (76:260–267), table 1 contains two errors in the
“Nucleotide Change” column. For family 24, the correct
nucleotide change for the mutation is 901CrT. For family
26, the correct nucleotide change for the mutation is 510-
2ArG. We have also modiﬁed the notation in the “Nu-
cleotide Change” column for families 25 and 29, to follow
the guidelines for mutation nomenclature found at the
Human Genome Variation Society Web site (http://www
.genomic.unimelb.edu.au/mdi/mutnomen/) and in the
work of den Dunnen and Antonarakis.1 The authors regret
the errors.
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Table 1. Mutations and Expression Data in Affected Males from the Five Families
Family
Patient’s
Age at
Examination
(years)
PIP2
Phosphatase
Activitya
(nmol/min/mg)
Level of
OCRL Protein
(Western
Blot)b Exon
Mutation
Type
Nucleotide
Change
Effect on
Translation
Screening
Method
No. of
Normal X
Chromosomes
Screened
20 9 .63  14 Substitution c.1385ArG Y462C (TyrrCys) RFLP (Tsp451) 120
24c 22/27 .76/.85 / 11 Substitution c.901CrT R301C (ArgrCys) RFLP (Hha1) 132
25 8 .42  7 2-base insertion c.438_439dupAA I147K, Stop Allele-speciﬁc PCR 106
29 10 .49  5 4-base deletion c.261_264delTTTG C87Stop RFLP (Eco571) 106
26 9 .54  Intron 7 (5′
of exon 8)
Splice-site mutation c.510-2ArG Unknown (likely
frameshift)
RFLP (BfaI) 112
a Control ﬁbroblast, 4.71 nmol/min/mg; Lowe ﬁbroblast, 0.52 nmol/min/mg.
b Control ﬁbroblast, ; Lowe ﬁbroblast, .
c There were two affected brothers in this family.
